1. Home
  2. WVE vs SYNA Comparison

WVE vs SYNA Comparison

Compare WVE & SYNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.19

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Synaptics Incorporated $0.001 Par Value

SYNA

Synaptics Incorporated $0.001 Par Value

HOLD

Current Price

$134.54

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
SYNA
Founded
2012
1986
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.8B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
WVE
SYNA
Price
$6.19
$134.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
9
Target Price
$29.81
$100.78
AVG Volume (30 Days)
3.9M
1.0M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
$663,588,000.00
Revenue This Year
N/A
$12.63
Revenue Next Year
$85.67
$9.67
P/E Ratio
N/A
N/A
Revenue Growth
149.43
21.04
52 Week Low
$5.02
$58.28
52 Week High
$21.73
$149.11

Technical Indicators

Market Signals
Indicator
WVE
SYNA
Relative Strength Index (RSI) 35.45 62.29
Support Level $6.02 $65.22
Resistance Level $7.65 N/A
Average True Range (ATR) 0.35 9.07
MACD 0.05 -0.31
Stochastic Oscillator 15.04 60.50

Price Performance

Historical Comparison
WVE
SYNA

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SYNA Synaptics Incorporated $0.001 Par Value

Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.

Share on Social Networks: